Methyldopa

This classification denotes a dopamine agonist and antihypertensive agent with the molecular formula 2C10H13NO4.3H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 56LH93261Y, chemically known as 3,4-dihydroxy-2-methylphenylalanine but generally known as methyldopa, which bears US NIH Compound Identifier 4138. European Medicines Agency schedules Methyldopa in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08867MIG. World Health Organization schedules methyldopa in its Anatomical Therapeutic Chemical (ATC) Classification. METHYLDOPA is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule methyldopa under HS 29225000 and SITC 51467. As of Q4 2014, METHYLDOPA remains the US FDA Preferred Term for this commodity. Methyldopa bears US NLM identifiers UMLS ID C0025741 and NCI Concept Code C47616. SMILES: CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)N.